Jose Fernando Moura, PhD路 @FernandoOnco 路 X路路 14 hours agoScore70
Body
DeLLphi-305 delivered the data, but Dr. Stephen Liu DeLLivered the oracle! 馃敟
Just like Delphi in ancient Greece, he turned complex findings into wisdom.
A GIANT discussion by a giant in thoracic oncology! 馃憦
#ESMO26 @myESMO #SCLC
@StephenVLiu @BalazsHalmosMD @OncoAlert @lungoncdoc
70 views 路 3 likes 路 2 reposts 路 0 replies
Conference abstracts
LBA3matched by Presidential Symposium I
Tarlatamab plus durvalumab (durva) vs durva as 1L maintenance (1LM) therapy following durva, platinum, and etoposide (1L durva + EP) in extensive-stage small cell lung cancer (ES-SCLC): Primary analysis of the phase 3 DeLLphi-305 trial
https://esmocongress.esmo.orgSource: Jose Fernando Moura, PhD 路 x.com